Recent Study: Diabetic Foot Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

July 15, 2012 - PRLog -- GlobalData, the industry analysis specialist, has released its new report, "Diabetic Foot Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Diabetic Foot Ulcers Therapeutics market. The report identifies the key trends shaping and driving the global Diabetic Foot Ulcers Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Diabetic Foot Ulcers Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/439757_diabetic_foot_ulcer_therapeutics_pipeline.aspx
------------------------------------------------------------

Scope

The report provides information on the key drivers and challenges of the Diabetic Foot Ulcers Therapeutics market. Its scope includes -

* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Diabetic Foot Ulcers Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Diabetic Foot Ulcers Therapeutics market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Diabetic Foot Ulcers Therapeutics market.
* Analysis of key recent licensing and partnership agreements in Diabetic Foot Ulcers Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Diabetic Foot Ulcers Therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Diabetic Foot Ulcers Therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Diabetic Foot Ulcers Therapeutics market landscape? - Identify, understand and capitalize.

Companies Mentioned in this Report: Pfizer Inc., Cardiovascular Biotherapeutics, Inc., HealOr Ltd., MacroCure Ltd.

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Diabetic Foot Ulcer Therapeutics - Introduction
2.1 Overview
2.1.1 Diabetic Foot Ulcer Classification Systems
2.2 Epidemiology
2.2.1 Historic Epidemiology (2006-2011)
2.2.2 Forecast Epidemiology (2011-2019)
2.3 Prognosis
2.4 Etiology
2.5 Symptoms
2.6 Diagnosis
2.6.1 History
2.6.2 Neurologic Examination
2.6.3 Vascular Examination
2.6.4 Musculoskeletal Examination
2.6.5 Wound Evaluation
2.6.6 Laboratory Testing and Imaging Studies
2.7 Pathophysiology
2.8 Treatment and Management Pattern
2.8.1 Infection Control
2.8.2 Mechanical Load Relief
2.8.3 Wound Care/Debridement
2.8.4 Blood Glucose Control
2.8.5 Patient Education
2.9 Referral Pathway
2.10 GlobalData Pipeline Report Guidance
3 Diabetic Foot Ulcer Therapeutics - Market Characterization
3.1 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - Global
3.2 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - Global
3.3 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - The US
3.4 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - The US
3.5 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - France
3.6 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - France
3.7 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - Germany
3.8 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - Germany
3.9 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - Italy
3.10 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - Italy
3.11 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - Spain
3.12 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - Spain
3.13 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - The UK
3.14 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - The UK
3.15 Diabetic Foot Ulcer Therapeutics Market Size (2006-2011) - Japan
3.16 Diabetic Foot Ulcer Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Diabetic Foot Ulcer Therapeutics Market
3.17.1 Drivers of the Diabetic Foot Ulcer Therapeutics Market
3.17.2 Barriers for the Diabetic Foot Ulcer Therapeutics Market
3.18 Opportunity and Unmet Need
3.19 Key Takeaway

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4397...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.